Best practices to fund, develop and commercialize evidence-based mental health innovation
In this session we discuss key lessons learned for scientists and start-ups to successfully bring to market evidence-based innovative solutions. We will present non-dilutive funding opportunities and commercialization resources offered through the US small business research programs, and a scientist and inventor turned serial entrepreneur wrap-ups the day sharing insights from his previous venture–funded by the NIMH and sold to McKesson–and his current strategy and vision.
- Chair: Dr. Alison Fenney, Executive Director of the Neurotechnology Industry Organization
- Dr. Margaret Grabb, SBIR/STTR Program Director at the National Institute of Mental Health (NIMH)
- Dr. Rex Jakobovits, Founder of Vivalog Technologies and Experiad
These presentations took place at the 2016 SharpBrains Virtual Summit: Reinventing Brain Health in the Digital Age (December 6–8th, 2016).